Fragmento

High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome Most of us dealing with decompensated liver disease agonize when managing patients with hepatorenal syndrome (HRS) since its outcomes remain poor in spite all the advancement we have made in hepatology. When considering relatively expensive therapies such as intravenous terlipressin, predicting futile cases as early as possible will help reintroduce compassion to a technologically driven medicine.

Palabras clave:

2013-07-08   |   257 visitas   |   Evalua este artículo 0 valoraciones

Vol. 12 Núm.1. Enero-Febrero 2013 Pags. 4-5 Ann Hepatol 2013; 12(1)